Kalif Eliyahu Sharon, CFO of Teva Pharmaceutical Industries TEVA, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $20.7M. The latest trade was on 06/11.

KS

KS

Kalif Eliyahu Sharon

EVP, CFO

Company

Teva Pharmaceutical Industries TEVA

First filing

23/02/09

Trades

57 trades

Buys / sales

0 / 7

12-month net buying

−$20.7M

Last trade

06/11

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Teva Pharmaceutical IndustriesTEVA	Open-market sale10b5-1 plan	06/11	06/16	106,563 sh	$34.10	$3,633,798.3	−61.9%
Teva Pharmaceutical IndustriesTEVA	Open-market sale10b5-1 plan	05/14	05/18	153,251 sh	$35.61	$5,457,268.11	−47.1%
Teva Pharmaceutical IndustriesTEVA	Open-market sale10b5-1 plan	02/26	03/02	345,810 sh	$33.64	$11,633,048.4	−85.7%
Teva Pharmaceutical IndustriesTEVA	Open-market sale10b5-1 plan	25/06/12	25/06/16	55,775 sh	$17.08	$952,637	−12.1%
Teva Pharmaceutical IndustriesTEVA	Open-market sale10b5-1 plan	25/02/28	25/03/04	55,750 sh	$16.21	$903,707.5	−27.4%
Teva Pharmaceutical IndustriesTEVA	Open-market sale10b5-1 plan	24/03/06	24/03/07	77,550 sh	$13.52	$1,048,476	−27.6%
Teva Pharmaceutical IndustriesTEVA	Open-market sale	23/08/07	23/08/09	35,125 sh	$9.73	$341,766.25	−26.2%